This summary was created by AI, based on 3 opinions in the last 12 months.
Levi Strauss & Co. has recently seen mixed financial performance according to various expert reviews. The company's latest report highlighted a robust 12% year-over-year sales growth, particularly strong in the Americas, Europe, and direct-to-consumer channels, although higher expenses tempered an otherwise positive earnings report. However, there is some concern over a minor sales miss in one instance, coupled with a cut in the full-year revenue forecast, while still managing to assert that earnings would likely meet previous guidance midpoints. This indicates a varied performance, with strengths noted in Europe and direct-to-consumer sales, yet weakness in the Asian and American markets. Despite this mixed landscape, Levi’s stock has appreciated significantly this year, indicating some level of investor confidence, even as experts express divergent views on the outlook and overall performance going forward.
They just reported a minor sales miss but an earnings beat and cut their full-year revenue forecast though asserted their earnings would meet the midpoint of previous guidance. Europe and direct-to-consumer are strong, but Asian and America are weaker.
They just reported a slight revenue, but a strong earnings beat but didn't adjust their guidance. Shares are up 40% this year.
Could benefit from the weight-loss drug boom, because those who take those drugs will need need jeans. But the company reported a weak quarter and cut guidance.
Today, it reported an earnings and sales beat, but shares fell 16%. They lowered their full-year gross margin outlook a lot, but didn't touch earnings guidance. Also, they forecast a sales decline around 8-12% this quarter.
Levi Strauss & Co. is a American stock, trading under the symbol LEVI-N on the New York Stock Exchange (LEVI). It is usually referred to as NYSE:LEVI or LEVI-N
In the last year, 2 stock analysts published opinions about LEVI-N. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Levi Strauss & Co..
Levi Strauss & Co. was recommended as a Top Pick by on . Read the latest stock experts ratings for Levi Strauss & Co..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered Levi Strauss & Co. In the last year. It is a trending stock that is worth watching.
On 2025-03-18, Levi Strauss & Co. (LEVI-N) stock closed at a price of $16.45.
It reported after the bell superb 12% YOY sales growth, strength in the Americas, Europe and direct to consumer channels. They beat gross margins, but due to higher expenses, they delivered a modest earnings beat. Their full-year forecast was a little mixed, but overall good.